Evoke Pharma (EVOK) Misses Q1 EPS by 20c

Evoke Pharma (NASDAQ: EVOK) reported Q1 EPS of ($0.37), $0.20 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• The Gap, Inc. (GAP) Tops Q2 EPS by 3c
• Hormel Foods (HRL) Tops Q3 EPS by 2c, Misses on Revenue; Offers FY26 Guidance
• SolarEdge (SEDG) PT Lowered to $31 at Jefferies, 'We see shares as an unappealing short, not a compelling long'